Population Pharmacokinetics of Cyclosporine in Chinese Pediatric Patients With Acquired Aplastic Anemia

Population Pharmacokinetics of Cyclosporine in Chinese Pediatric Patients With Acquired Aplastic Anemia

Cyclosporine (CsA) is a component of the first-line treatment for acquired aplastic anemia (acquired AA) in pediatric patients. This study aimed to develop a population pharmacokinetic (PK) model of CsA in Chinese pediatric patients with acquired AA to inform individual dosage regimens. A total of 6...

Full description

Bibliographic Details
Main Authors:	Xuan Gao, Zhu-Li Bian, Xiao-Hong Qiao, Xiao-Wen Qian, Jun Li, Guo-Mei Shen, Hui Miao, Yi Yu, Jian-Hua Meng, Xiao-Hua Zhu, Jun-Ye Jiang, Jun Le, Ling Yu, Hong-Sheng Wang, Xiao-Wen Zhai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Pharmacology
Subjects:	cyclosporine population pharmacokinetics NONMEM acquired aplastic anemia pediatric patients
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.933739/full

Similar Items

Acquired severe aplastic anemia treated with antithymocyte globulin and cyclosporine: An experience of regional cancer center, Western India
by: Ankit B Patel, et al.
Published: (2015-01-01)

Aberrant myelomonocytic CD56 expression predicts response to cyclosporine therapy in pediatric patients with moderate aplastic anemia
by: Shanshan Qi, et al.
Published: (2023-12-01)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
by: Xuan Gao, et al.
Published: (2021-07-01)

Effects of Cyclosporine and Azacitidine on Some Hematologic and ‎Biochemical Parameters of Benzene-Induced Aplastic Anemia in Rats
by: ghanem taher, et al.
Published: (2023-12-01)

Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
by: Lan-Ping Xu, et al.
Published: (2019-09-01)

The efficacy and safety of cyclosporine A plus androgen versus androgen alone for adult patients with non-severe aplastic anemia in China: a meta-analysis of randomized controlled trials
by: Xiao-tian Zhang, et al.
Published: (2022-12-01)

Immunosuppressive Treatment in Children with Acquired Aplastic Anemia
by: Yıldız Yıldırmak, et al.
Published: (2012-05-01)

Effective Tacrolimus Treatment for Patients with Non-Severe Aplastic Anemia That is Refractory/Intolerant to Cyclosporine A: A Retrospective Study
by: Du Y, et al.
Published: (2020-12-01)

Use of Cyclosporine A and danazol in treatment of aplastic anemia: A real-world data from a teaching hospital in South India
by: Girish Kamat, et al.
Published: (2022-10-01)

Immunosupressive therapy of aplastic anemia patients: successes and failures (single center experiment 2007–2016)
by: E. A. Mikhaylova, et al.
Published: (2020-09-01)

A new model for the population pharmacokinetics of didanosine in healthy subjects
by: L.S. Velasque, et al.
Published: (2007-01-01)

Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant
by: Lan-Ping Xu, et al.
Published: (2017-01-01)

Aplastic Anemia Complicating Systemic Lupus Erythematosus
by: Anu Maheshwari, et al.
Published: (2021-01-01)

Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy
by: Zhan-zhang Wang, et al.
Published: (2019-07-01)

Idiopathic Aplastic Anemia: An Update
by: Elena E. Solomou
Published: (2019-03-01)

External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients
by: Yan Qin, et al.
Published: (2023-12-01)

Red blood cell distribution width as a prognostic factor in patients with aplastic anemia treated with cyclosporin A plus androgen or cyclosporine A alone: a retrospective study
by: Xiaotian Zhang, et al.
Published: (2023-12-01)

Population Pharmacokinetics of Tigecycline: A Systematic Review
by: Zhou CC, et al.
Published: (2022-06-01)

Hematopoietic Stem Cell Transplantation in Patients with Severe Acquired Aplastic Anemia: Iranian Experience
by: Masoud Iravani, et al.
Published: (2011-10-01)

Hematopoietic Stem Cell Transplantation in Patients with Severe Acquired Aplastic Anemia: Iranian Experience
by: Mahdi Jalili, et al.
Published: (2011-12-01)

Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia
by: Jiali Huo, et al.
Published: (2020-02-01)

Aplastic anaemia caused bythiamazole: A case report
by: Milošević Rajko, et al.
Published: (2004-01-01)

APLASTIC ANEMIA
by: Ni Made Dharma Laksmi, et al.
Published: (2013-07-01)

All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia
by: Bianca Serio, et al.
Published: (2023-12-01)

Acquired pure megakaryocytic aplasia successfully treated with cyclosporine
by: Halima El Omri, et al.
Published: (2010-12-01)

Acquired pure megakaryocytic aplasia successfully treated with cyclosporine
by: Halima El Omri, et al.
Published: (2010-12-01)

Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical Studies
by: Li Y, et al.
Published: (2020-07-01)

High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study
by: Yuan Yang, et al.
Published: (2024-12-01)

Donepezil Brain and Blood Pharmacokinetic Modeling after Nasal Film and Oral Solution Administration in Mice
by: Christos Kaikousidis, et al.
Published: (2023-05-01)

Severe Generalized Periodontitis in a Patient with an Aplastic Anemia: a 5 Year Follow-up Case Report
by: Ivan Puhar, et al.
Published: (2015-01-01)

Transfusion-dependent non-severe aplastic anemia: characteristics and outcomes in the clinic
by: Yawen Zhang, et al.
Published: (2023-07-01)

Acquired Amegakaryocytic Thrombocytopenia Progressingto Aplastic Anaemia
by: Syed Ather Hussain, et al.
Published: (2022-09-01)

Current management of severe acquired aplastic anemia
by: Phillip Scheinberg
Published: (2011-06-01)

The Pharmacokinetic Profile of Freeze-dried Cyclosporine A-Eudragit S100 Nanoparticle Formulation in Dogs
by: Yang Liu, et al.
Published: (2011-03-01)

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A
by: Marlene Pereira Garanito, et al.
Published: (2014-09-01)

Impaired immunosuppressive effect of bone marrow mesenchymal stem cell-derived exosomes on T cells in aplastic anemia
by: Shichong Wang, et al.
Published: (2023-10-01)

No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses
by: Martin Šíma, et al.
Published: (2021-07-01)

Dose Tailoring of Vancomycin Through Population Pharmacokinetic Modeling Among Surgical Patients in Pakistan
by: Muhammad Muaaz Munir, et al.
Published: (2021-11-01)

The Pharmacokinetic and Absolute Bioavailability of Cyclosporine (Atopica for Cats<sup>®</sup>) in Cats
by: Jingyuan Kong, et al.
Published: (2023-06-01)

Population Pharmacokinetic Study of Benzylpenicillin in Critically Unwell Adults
by: Reya V. Shah, et al.
Published: (2023-03-01)